| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 06/10/2003 | US6576159 Colorants, electroconductive materials; solubility, dissociation |
| 06/10/2003 | CA2055670C Retroviral protease inhibiting compounds |
| 06/10/2003 | CA2040489C 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments |
| 06/05/2003 | WO2003045957A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 06/05/2003 | WO2003045930A1 Therapeutic compounds |
| 06/05/2003 | WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 06/05/2003 | WO2003045386A1 Benzothiazole derivatives |
| 06/05/2003 | WO2003045385A1 Benzothiazole derivatives |
| 06/05/2003 | WO2003045384A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/05/2003 | WO2003045334A2 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 06/05/2003 | WO2003045324A2 14-methyl-epothilones |
| 06/05/2003 | WO2002098902A3 Improved native chemical ligation with three or more components |
| 06/05/2003 | WO2002048124A3 Piperazine derivatives |
| 06/05/2003 | US20030105333 RXR activating molecules |
| 06/05/2003 | US20030105331 Use as anorectics, treating obesity and type II diabetes; C2-substituent is a sulfonyl-, sulfinyl- or sulfide-containing group, and indan 1-hydroxy group is esterified, etherified or a carbonate group |
| 06/05/2003 | US20030105330 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 06/05/2003 | US20030105161 Analgesics; antiinflamamtory agents |
| 06/05/2003 | US20030105148 Selective estrogen receptor modulators |
| 06/05/2003 | US20030105147 Analgesics, sedatives, anesthetics |
| 06/05/2003 | US20030105142 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/05/2003 | US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 06/05/2003 | US20030105099 Novel compounds and compositions as cathepsin inhibitors |
| 06/05/2003 | US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 06/05/2003 | US20030105071 For therapy of addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, Parkinson's disease, restless leg syndrome, sleeping disorders |
| 06/05/2003 | US20030101925 Novel stable crystal of thiazolidinedione derivative and process for producing the same |
| 06/05/2003 | CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 06/05/2003 | CA2468422A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 06/05/2003 | CA2467825A1 Benzothiazole derivatives |
| 06/04/2003 | EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 06/04/2003 | CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 06/04/2003 | CN1110497C Di-or triaza-spiral [4,5] decane derivative |
| 06/03/2003 | US6573339 Reacting a mixture consisting of an N-hydrocarbyl-2-benzothiazolesulfenamide and an anhydride of an aliphatic dicarboxylic acid containing four to six carbon atoms in situ in a natural or synthetic elastomer matrix |
| 06/03/2003 | US6573289 Naphthalene derivatives, their production and use |
| 06/03/2003 | US6573268 Administering novel azolidinedione derivatives, tautomers, stereoisomers, polymorphs, pharmaceutically acceptable salts and solvates to treat diabetes |
| 06/03/2003 | US6573264 Heteroaryl alkyl piperazine derivatives |
| 06/03/2003 | US6573218 Fused-benzene derivatives useful as herbicides |
| 06/03/2003 | CA2053954C Process for the preparation of nitroguanidine derivatives |
| 05/30/2003 | WO2003044877A2 Light emitting device and compounds for use therein |
| 05/30/2003 | WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/30/2003 | WO2003043999A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 05/30/2003 | WO2003043998A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases |
| 05/30/2003 | WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease |
| 05/30/2003 | WO2003043577A2 Modulators of rho c activity |
| 05/30/2003 | CA2467476A1 Amino diols useful in the treatment of alzheimer's disease |
| 05/30/2003 | CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/29/2003 | US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 05/29/2003 | US20030100587 New substituted 2,4-thiazolidinedione derivatives, processes for producing them and pharmaceutical compositions containing them |
| 05/29/2003 | US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid |
| 05/29/2003 | US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 05/29/2003 | US20030100545 Psychological disorder treatments that increase the activity of cholinergic receptors |
| 05/28/2003 | EP1314981A2 Benzo[c,d]indole-fluorochromes for labelling biomolecules and polymer particles |
| 05/28/2003 | EP1314426A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 05/28/2003 | EP1313731A1 Thiazolidine derivatives and its use as antifungal agent |
| 05/28/2003 | EP1313724A1 N-heteroarylmethyl-p-phenylendiamine derivatives and compounds containing oxidation colouring agents |
| 05/28/2003 | EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 05/28/2003 | EP1313719A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
| 05/28/2003 | EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 05/28/2003 | EP1313700A1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds |
| 05/28/2003 | EP1313477A1 Compounds and methods |
| 05/28/2003 | EP1313471A1 Benzylidene thiazolidinediones and their use as antimycotic agents |
| 05/28/2003 | EP1230229B1 Method for producing 2-chloro-5-chloromethyl-1,3-thiazol |
| 05/28/2003 | EP1015444B1 Pyrimidine derivatives and processes for the preparation thereof |
| 05/28/2003 | CN1420884A 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders |
| 05/28/2003 | CN1420797A Method for improvement of islet signaling in diabetes mellitus and for its prevention |
| 05/28/2003 | CN1109544C Beta-alkoxyacrylates against malaria |
| 05/27/2003 | US6570021 Intermediates for the preparation of 2-imidazolin-5-ones |
| 05/27/2003 | US6569884 Conformationally rigid bicyclic and adamantane derivatives useful as α2-adrenergic blocking agents |
| 05/27/2003 | US6569882 Viricides; enzyme inhibitors |
| 05/27/2003 | US6569878 Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors |
| 05/27/2003 | US6569877 Benzimidazolyl phenyl anticancer agents |
| 05/27/2003 | US6569874 Such as 2-acetylamino-4-(3-amidinophenyl)-5-((2'-amino-sulfonyl-(1,1')-biphen-4 -yl)aminocarbonyl)thiazole; for treatment of thromboembolic disorders |
| 05/27/2003 | US6569873 Azolidines as beta-3 adrenergic receptor agonists |
| 05/27/2003 | US6569856 Treatment of feeding disorders, obesity, bulimia nervosa, sexual/reproductive disorders, depression, epileptic seizure, cardiovascular disorders, sleep disturbances |
| 05/27/2003 | CA2412624A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurogenerative diseases |
| 05/22/2003 | WO2003042199A1 Agent and method for coloring keratin fibers containing 2-benzothiazolinone-hydrazone and quinone derivatives |
| 05/22/2003 | WO2003042194A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient |
| 05/22/2003 | WO2003042185A1 Xanthine oxidase inhibitors |
| 05/22/2003 | WO2003042168A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES |
| 05/22/2003 | WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES |
| 05/22/2003 | WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 05/22/2003 | WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 05/22/2003 | WO2003042147A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents |
| 05/22/2003 | WO2003041728A1 Novel phenyl-propargylether derivatives |
| 05/22/2003 | WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors |
| 05/22/2003 | WO2003024943A3 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 05/22/2003 | WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 05/22/2003 | US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists |
| 05/22/2003 | US20030096864 Compounds to treat alzheimer's disease |
| 05/22/2003 | US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite |
| 05/22/2003 | US20030096849 For therapy of cancer, ras oncogene-dependent tumors, such as cancers of the pancreas, colon, bladder, and thyroid |
| 05/22/2003 | US20030096846 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 05/22/2003 | US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 05/22/2003 | US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/22/2003 | US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders |
| 05/22/2003 | US20030096381 Production of polyketides |
| 05/22/2003 | US20030096374 Synthesis of oligoketides |
| 05/22/2003 | US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/22/2003 | US20030093867 Hair dyes; intense, stable blue color shades in addition to natural, purple or violet ones |
| 05/22/2003 | CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 05/22/2003 | CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors |